Terlipressin: Important Safety Information from Ferring Ireland Limited as approved by the HPRA (15.12.22)

Notice type: 3rd Party Publications

Date: 21/12/2022




Problem Or Issue:
Important Safety Information from Ferring Ireland Limited regarding Terlipressin: Serious or fatal respiratory failure and sepsis/septic shock in patients with type 1 hepatorenal syndrome (type 1 HRS)

Important Safety Information – Terlipressin 


« Back